These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 16457162

  • 1. [Docetaxel and novel strategies in the treatment of NSCLC].
    Longo F, Mansueto G.
    Tumori; 2005; 91(6):suppl 11-22. PubMed ID: 16457162
    [No Abstract] [Full Text] [Related]

  • 2. Docetaxel in advanced non-small cell lung cancer.
    Wakelee H, Ramalingam S, Belani CP.
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):13-24. PubMed ID: 15757434
    [Abstract] [Full Text] [Related]

  • 3. Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel.
    Csiki I, Morrow JD, Sandler A, Shyr Y, Oates J, Williams MK, Dang T, Carbone DP, Johnson DH.
    Clin Cancer Res; 2005 Sep 15; 11(18):6634-40. PubMed ID: 16166442
    [Abstract] [Full Text] [Related]

  • 4. [Docetaxel (taxotere) in non-small-cell bronchial carcinoma].
    Manegold C.
    Med Klin (Munich); 1997 Sep 15; 92 Suppl 4():10-5. PubMed ID: 9446014
    [Abstract] [Full Text] [Related]

  • 5. [Toward the cure of "early-stage" solid tumors: the role of docetaxel].
    Mansueto G, Longo F.
    Tumori; 2005 Sep 15; 91(4):suppl 17-28. PubMed ID: 16277113
    [No Abstract] [Full Text] [Related]

  • 6. The development of docetaxel (Taxotere) in non-small cell lung cancer.
    Kris MG, Miller VA, Ng KK, Grant SC.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
    [No Abstract] [Full Text] [Related]

  • 7. Docetaxel as monotherapy in the treatment of advanced non-small-cell lung cancer in elderly patients.
    Malani AK, Abou-Jawde RM, Singh J, Taylor SA.
    J Clin Oncol; 2007 Mar 20; 25(9):1143-4; author reply 1144. PubMed ID: 17369581
    [No Abstract] [Full Text] [Related]

  • 8. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
    Khuri FR.
    Oncology (Williston Park); 2002 Jun 20; 16(6 Suppl 6):53-62. PubMed ID: 12108898
    [Abstract] [Full Text] [Related]

  • 9. Taxanes, past, present, and future impact on non-small cell lung cancer.
    Joshi M, Liu X, Belani CP.
    Anticancer Drugs; 2014 May 20; 25(5):571-83. PubMed ID: 24463482
    [Abstract] [Full Text] [Related]

  • 10. [Taxol in bronchial carcinoma].
    Gatzemeier U.
    Med Klin (Munich); 1996 Dec 15; 91 Suppl 2():1-6. PubMed ID: 9082171
    [No Abstract] [Full Text] [Related]

  • 11. Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial.
    Nugent FW, Mertens WC, Graziano S, Levitan N, Collea R, Gajra A, Marshall J, McCann J.
    Lung Cancer; 2005 May 15; 48(2):267-73. PubMed ID: 15829328
    [Abstract] [Full Text] [Related]

  • 12. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model.
    Fulzele SV, Chatterjee A, Shaik MS, Jackson T, Singh M.
    Pharm Res; 2006 Sep 15; 23(9):2094-106. PubMed ID: 16902813
    [Abstract] [Full Text] [Related]

  • 13. Docetaxel in the treatment of advanced non-small-cell lung cancer.
    Saloustros E, Georgoulias V.
    Expert Rev Anticancer Ther; 2008 Aug 15; 8(8):1207-22. PubMed ID: 18699760
    [Abstract] [Full Text] [Related]

  • 14. [AIOM Conference 2004. Revision of the role of docetaxel in non-small cell lung cancer].
    Gamucci T, Mansueto G.
    Tumori; 2004 Aug 15; 90(6):22-9. PubMed ID: 15762374
    [No Abstract] [Full Text] [Related]

  • 15. The current status of docetaxel for advanced non-small cell lung cancer.
    Green MR.
    Anticancer Drugs; 2001 Feb 15; 12 Suppl 1():S11-6. PubMed ID: 11340898
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.
    Patel AR, Chougule MB, I T, Patlolla R, Wang G, Singh M.
    Pharm Res; 2013 May 15; 30(5):1435-46. PubMed ID: 23361589
    [Abstract] [Full Text] [Related]

  • 17. Docetaxel (Taxotere) in the treatment of non-small cell lung cancer.
    Kris MG, Millward M.
    Semin Oncol; 1999 Jun 15; 26(3 Suppl 10):1-2. PubMed ID: 10437742
    [No Abstract] [Full Text] [Related]

  • 18. Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer.
    Betticher DC, Rosell R.
    Lung Cancer; 2004 Dec 15; 46 Suppl 2():S23-32. PubMed ID: 15698528
    [Abstract] [Full Text] [Related]

  • 19. Two-dimensional radiotherapy and docetaxel in treatment of stage III non-small cell lung carcinoma: no good survival due to radiation pneumonitis.
    Dinçbas FO, Atalar B, Koca S.
    Lung Cancer; 2004 Feb 15; 43(2):241-2. PubMed ID: 14739045
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.